Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells
Pre-publication versions of this article are available by contacting email@example.com.
|24 Nov 2015||Submitted||Original manuscript|
|26 Apr 2016||Reviewed||Reviewer Report - Dana Roque|
|4 Aug 2016||Reviewed||Reviewer Report - Suman Rice|
|9 Aug 2016||Reviewed||Reviewer Report - Jeremy Chien|
|25 Oct 2016||Author responded||Author comments - Juan Du|
|Resubmission - Version 2|
|25 Oct 2016||Submitted||Manuscript version 2|
|20 Nov 2016||Reviewed||Reviewer Report - Suman Rice|
|21 Nov 2016||Reviewed||Reviewer Report - Jeremy Chien|
|3 Mar 2017||Author responded||Author comments - Juan Du|
|Resubmission - Version 3|
|3 Mar 2017||Submitted||Manuscript version 3|
|29 Jun 2017||Author responded||Author comments - Juan Du|
|Resubmission - Version 4|
|29 Jun 2017||Submitted||Manuscript version 4|
|23 Nov 2017||Editorially accepted|
|14 Dec 2017||Article published||10.1186/s12885-017-3840-1|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.